View Clinical Trial (Medical Research Study)
Study of Naltrexone for Methamphetamine Addiction - NCT00984360-94110(Clinical Trial 352653)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
San Francisco |
|
State:
|
|
CA |
| Zip Code: |
|
94110 |
| Conditions: |
|
Methamphetamine Dependence |
| Purpose: |
|
The purpose of this study is to determine whether methamphetamine-dependent individuals will
use less methamphetamine when treated with naltrexone. The study will also investigate
whether individuals with the mu opioid receptor gene variant A118G will use less
methamphetamine than individuals without A118G.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Age between 18 and 50 years
- Patient is agreeable to conditions of study and signs consent form |
|
|
|
| Study is available at: |
|
Addiction & Pharmacology Research Laboratory
San Francisco, CA 94110
United States
Primary Contact:
Emma Olson
Email: OlsonE@cpmcri.org
Phone: 415-641-3370
Secondary Contact:
Emma Olson
Email: OlsonE@cpmcri.org
Phone: 415-641-3370 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|